Latest Headlines

  1. Beckman Coulter Life Sciences Launches Industry-First Modular Spectral Flow Cytometry Solution 3/18/2025

    Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation revolutionizes spectral flow cytometry with the industry’s first modular solution: the CytoFLEX mosaic Spectral Detection Module.

  2. Tecsys Expands Global Reach With Roche's Adoption Of Elite™ For Laboratory Inventory Management 3/18/2025

    Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, announced that Roche, the world's largest biotechnology company and global leader in in-vitro diagnostics, has selected Tecsys' Elite™ platform for implementation across Roche's network of core laboratory sites in over 50 countries, with a target of a thousand installations over the next five years.

  3. GE HealthCare Expands Invasive Cardiology Solutions Portfolio With AltiX AI.i For Elevated Experience In Catheterization Lab And Electrophysiology Procedures 3/17/2025

    GE HealthCare today announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab.

  4. Circular Genomics Joins Lilly Gateway Labs In San Diego To Develop Its Best-In-Class Circular RNA Platform For The Diagnosis And Prognosis Of Alzheimer's Disease 3/17/2025

    Circular Genomics, a global leader in circular RNA (circRNA) biomarkers for precision neurology and psychiatry, today announced it is moving the company's headquarters to Lilly Gateway Labs in San Diego, California, which is operated in partnership with Alexandria Real Estate Equities, Inc., to advance the development of Alzheimer's disease (AD) biomarkers aimed at improving the identification and monitoring of the disease and its risk of progression.

  5. US Fertility Chooses Alife Health's Embryo Image Capture And Reporting Platform To Engage IVF Patients And Increase Clinical Efficiency Nationwide 3/17/2025

    Alife Health (Alife), a leading provider of AI-powered tools to advance the in-vitro fertilization (IVF) process, is excited to expand its partnership with US Fertility, the nation's largest partnership of physician-owned fertility practices.

  6. Versatile Single Tube Decapper/Recapper Reduces Strain And Streamlines Workflow 3/13/2025

    Engineered to handle a wide range of large-format tubes—including centrifuge, cell culture, and glass sample tubes (11-40mm) - the IntelliXcap S1 from Azenta Life Sciences eliminates the inconvenience of manual adjustments by accommodating multiple tube types without requiring a cap gripper change.

  7. Children's Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab 3/12/2025

    The Children's Hospital Colorado (Children's Colorado) Precision Medicine Institute today announces the recent opening of its innovative whole-genome sequencing lab that is revolutionizing the hospital's capabilities to make genomic results accessible and integrated into patient care.

  8. Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer To Evolving Needs Of Fertility Clinics, Biorepositories And Clinical Laboratories 3/12/2025

    Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers.

  9. Adaptive Biotechnologies Launches Assay Enhancements To Increase clonoSEQ® Sensitivity For Clinical MRD Detection In Diffuse Large B-Cell Lymphoma 3/11/2025

    Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that it has launched an upgraded version of its clonoSEQ assay for measurable residual disease (MRD) detection in diffuse large B-cell lymphoma (DLBCL) using circulating tumor DNA (ctDNA).

  10. Guardant Health Receives ADLT Status From CMS For Shield Blood Test 3/11/2025

    Guardant Health, Inc. a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test (ADLT) status for the Shield blood test for colorectal cancer (CRC) screening.